Pliant Therapeutics (PLRX) Stock Statistics & Valuation Metrics

Pliant Therapeutics has a market cap or net worth of $75.58M. The enterprise value is -$131.29M.

Pliant Therapeutics has 61,449,387 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pliant Therapeutics’s return on equity (ROE) is -0.69 and return on invested capital (ROIC) is -62.69%.

The current PE Ratio of Pliant Therapeutics is ―. Pliant Therapeutics’s PEG ratio is -0.14.

In the last 12 months, Pliant Therapeutics had revenue of 0.00 and earned -210.30M in profits. Earnings per share was -3.47.

In the last 12 months, operating cash flow was -158.21M and capital expenditures -583.00K, giving a free cash flow of -158.79M billion.

Pliant Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Pliant Therapeutics upcoming earnings date is Mar 3, 2026, After Close (Confirmed).

Pliant Therapeutics as a current ratio of 10.91, with Debt / Equity ratio of 14.69%

In the past 12 months, Pliant Therapeutics has paid 0.00 in taxes.

Pliant Therapeutics EV to EBITDA ratio is -3.44, with an EV/FCF ratio of -4.93.

Pliant Therapeutics has $241.80M in cash and marketable securities with $59.86M in debt, giving a net cash position of $181.94M billion.

Gross margin is 10.57%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Pliant Therapeutics is $3.00, which is 11.43% higher than the current price. The consensus rating is Hold